Warner Wellcome dissolved

Published on .

Warner-Lambert Co. said it has purchased Glaxo Wellcome's U.S. and European interest in the Warner Wellcome joint venture for $1.05 billion. Newly named Warner-Lambert Consumer Healthcare will market Sudafed, Actifed, Neosporin and other over-the-counter brands. Melvin R. Goodes, chairman-CEO, said the move "represents a giant step on the path to achieving our goal of becoming the leading OTC marketer by the end of the decade." No agency changes are expected.

Most Popular
In this article: